Dana Farber Cancer Institute Dept. Onc — Boston, Massachusetts

Dana Farber Cancer Institute Dept. Onc is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Dept. Onc has participated in 1 clinical trials.

Therapeutic areas: Uveal Melanoma.

Sponsors: Array Biopharma, now a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Dept. Onc?

Dana Farber Cancer Institute Dept. Onc has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Dept. Onc conducted?

Dana Farber Cancer Institute Dept. Onc has 1 clinical trials on record. Their work covers Uveal Melanoma.

Is Dana Farber Cancer Institute Dept. Onc accredited by Crixeo Health?

Dana Farber Cancer Institute Dept. Onc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Dept. Onc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.